Publication | Closed Access

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG

P-glycoprotein FunctionSynergistic ActivityCell RegulationMedicineImmunologyAnti-cancer AgentImatinib-resistant Cml CellsCell BiologyCell SignalingTumor Biology